{"id":"https://openalex.org/W2505264136","doi":"https://doi.org/10.1158/1538-7445.am2016-lb-170","title":"Abstract LB-170: Unique microRNA signatures in small cell lung cancer correlate with distinct protein expression profiles and drug response","display_name":"Abstract LB-170: Unique microRNA signatures in small cell lung cancer correlate with distinct protein expression profiles and drug response","publication_year":2016,"publication_date":"2016-07-15","ids":{"openalex":"https://openalex.org/W2505264136","doi":"https://doi.org/10.1158/1538-7445.am2016-lb-170","mag":"2505264136"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2016-lb-170","doi":"https://doi.org/10.1158/1538-7445.am2016-lb-170","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2016-lb-170","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057753889","display_name":"Carl Michael Gay","orcid":"https://orcid.org/0000-0002-4907-0718","observed_orcids":["https://orcid.org/0000-0002-4907-0718"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carl M. Gay","raw_affiliation_strings":["University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024573943","display_name":"Samrat T. Kundu","orcid":"https://orcid.org/0000-0002-0117-6986","observed_orcids":["https://orcid.org/0000-0002-0117-6986"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samrat Kundu","raw_affiliation_strings":["University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089771018","display_name":"Lixia Diao","orcid":"https://orcid.org/0000-0001-6995-4492","observed_orcids":["https://orcid.org/0000-0001-6995-4492"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lixia Diao","raw_affiliation_strings":["University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110967559","display_name":"Bonnie S. Glisson","orcid":"https://orcid.org/0009-0006-7320-2940","observed_orcids":["https://orcid.org/0009-0006-7320-2940"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bonnie S. Glisson","raw_affiliation_strings":["University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100378341","display_name":"Jing Wang","orcid":"https://orcid.org/0000-0002-5398-0802","observed_orcids":["https://orcid.org/0000-0002-5398-0802","https://orcid.org/0009-0006-4171-5397","https://orcid.org/0000-0002-8911-9555","https://orcid.org/0009-0003-0661-5954"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jing Wang","raw_affiliation_strings":["University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048380048","display_name":"John Victor Heymach","orcid":"https://orcid.org/0000-0001-9068-8942","observed_orcids":["https://orcid.org/0000-0001-9068-8942"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John V. Heymach","raw_affiliation_strings":["University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067755477","display_name":"Lauren A. Byers","orcid":"https://orcid.org/0000-0002-0780-2677","observed_orcids":["https://orcid.org/0000-0002-0780-2677"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lauren A. Byers","raw_affiliation_strings":["University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010884206","display_name":"Don Lynn Gibbons","orcid":"https://orcid.org/0000-0003-2362-3094","observed_orcids":["https://orcid.org/0000-0003-2362-3094"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Don L. Gibbons","raw_affiliation_strings":["University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"76","issue":"14_Supplement","first_page":"LB","last_page":"170"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10062","display_name":"MicroRNA in disease regulation","score":0.8359000086784363,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10062","display_name":"MicroRNA in disease regulation","score":0.8359000086784363,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.16200000047683716,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10515","display_name":"Cancer-related molecular mechanisms research","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/small-cell-lung-cancer","display_name":"small cell lung cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/microrna-signature","display_name":"microRNA signature","score":0.7879999876022339},{"id":"https://openalex.org/keywords/mir-200-family","display_name":"miR-200 family","score":0.7360000014305115},{"id":"https://openalex.org/keywords/mir-378","display_name":"miR-378","score":0.890999972820282},{"id":"https://openalex.org/keywords/mir-217","display_name":"miR-217","score":0.9779999852180481},{"id":"https://openalex.org/keywords/epithelial-mesenchymal-transition","display_name":"epithelial-mesenchymal transition","score":0.9169999957084656},{"id":"https://openalex.org/keywords/cisplatin-resistance","display_name":"cisplatin resistance","score":0.8690000176429749},{"id":"https://openalex.org/keywords/polo-like-kinase-1-inhibitor","display_name":"polo-like kinase 1 inhibitor","score":0.7599999904632568},{"id":"https://openalex.org/keywords/c-myc","display_name":"c-Myc","score":0.8399999737739563},{"id":"https://openalex.org/keywords/wee1","display_name":"WEE1","score":0.9010000228881836},{"id":"https://openalex.org/keywords/ppm1d","display_name":"PPM1D","score":0.7670000195503235},{"id":"https://openalex.org/keywords/trka","display_name":"TrkA","score":0.8420000076293945},{"id":"https://openalex.org/keywords/braf","display_name":"BRAF","score":0.9139999747276306},{"id":"https://openalex.org/keywords/immune-checkpoint-genes","display_name":"immune checkpoint genes","score":0.7039999961853027},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.7760000228881836},{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.5460000038146973},{"id":"https://openalex.org/keywords/drug-response","display_name":"drug response","score":0.4000000059604645},{"id":"https://openalex.org/keywords/molecular-subtypes","display_name":"molecular subtypes","score":0.6620000004768372},{"id":"https://openalex.org/keywords/tumor-heterogeneity","display_name":"tumor heterogeneity","score":0.4970000088214874}],"concepts":[{"id":"https://openalex.org/C145059251","wikidata":"https://www.wikidata.org/wiki/Q310899","display_name":"microRNA","level":3,"score":0.6768276691436768},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.59395432472229},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5906507968902588},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.5659894943237305},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.545606791973114},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4423447847366333},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.36226651072502136},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.26444220542907715},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.22968381643295288},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.20479071140289307},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.17045104503631592}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2016-lb-170","doi":"https://doi.org/10.1158/1538-7445.am2016-lb-170","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2016-lb-170","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2419167533","https://openalex.org/W2125621783","https://openalex.org/W2594319576","https://openalex.org/W2116996417","https://openalex.org/W4384039657","https://openalex.org/W2601462002","https://openalex.org/W2170529606","https://openalex.org/W6902075713","https://openalex.org/W4200431510","https://openalex.org/W3135038053"],"abstract_inverted_index":{"Abstract":[0],"In":[1,187],"the":[2,5,39,56,167,177,356,367,374,425,474,479],"decades":[3],"since":[4],"introduction":[6],"of":[7,10,38,75,129,194,203,214,233,251,318,370,473,478],"platinum-etoposide,":[8],"treatment":[9,57],"small":[11,457],"cell":[12,66,82,458],"lung":[13,67,459],"cancer":[14,68,460],"(SCLC)":[15],"remains":[16],"virtually":[17],"unchanged.":[18],"Data":[19],"from":[20],"our":[21,157],"lab":[22],"and":[23,54,102,142,261,267,282,322,335,362,377,385,405,422,467],"others":[24],"have":[25,151,343],"identified":[26,98],"novel":[27,419],"targets":[28,421],"now":[29],"being":[30],"investigated":[31],"in":[32,64,79,100,136,145,185,223,242,277,293,302,383,456],"clinical":[33],"trials.":[34],"However,":[35],"further":[36],"characterization":[37],"molecular":[40,420],"heterogeneity":[41,372,427],"within":[42],"SCLCs":[43],"will":[44],"be":[45],"critical":[46],"to":[47,60,88,117,138,166,179,249,346],"identify":[48,89],"subsets":[49],"with":[50,133,183,286,306,395,462],"specific":[51],"therapeutic":[52],"vulnerabilities":[53],"change":[55],"paradigm,":[58],"similar":[59],"what":[61],"has":[62],"occurred":[63],"non-small":[65],"(NSCLC).":[69],"Here":[70],"we":[71,96],"report":[72,369],"expression":[73,104,119,128,193,213,219,232,465],"analyses":[74],"2578":[76],"microRNAs":[77],"(miRs)":[78],"62":[80],"SCLC":[81,371,394],"lines,":[83,358],"followed":[84],"by":[85,126,211,230,275],"unsupervised":[86],"clustering":[87],"three":[90],"distinct":[91,396,463],"miR":[92,118,207,375,397],"subtypes.":[93],"Using":[94],"ANOVA,":[95],"then":[97],"differences":[99,382],"mRNA":[101,384],"protein":[103,108,252,386,404,464],"(by":[105],"reverse":[106],"phase":[107],"array),":[109],"as":[110,112,161,163,244,246,290,311,388,390],"well":[111,162,245,389],"drug":[113,391,406,417,468],"response,":[114,418],"which":[115,180],"corresponded":[116],"profiles.":[120,398],"The":[121,270],"first":[122,368],"subtype":[123,190,208,226,272,298],"is":[124,181,209,227,273,366],"characterized":[125],"low":[127,149],"miR-200,":[130],"a":[131,200,216,239,284,287,339,409],"family":[132,217,285],"known":[134,201],"function":[135],"epithelial":[137],"mesenchymal":[139],"transition":[140],"(EMT)":[141],"previously":[143],"implicated":[144],"cisplatin":[146,221],"resistance.":[147],"miR-200":[148],"lines":[150],"significantly":[152],"higher":[153],"EMT":[154,159,184],"scores":[155],"(using":[156],"published":[158],"signature),":[160],"increased":[164,192,231,247],"sensitivity":[165,178,222,248,392],"polo-like":[168],"kinase":[169,258],"1":[170,315],"(PLK-1)":[171],"inhibitor":[172],"GW843682X":[173],"(p":[174,196,235,263,330],"=":[175,197,236,264,331],"0.007),":[176],"associated":[182,305],"NSCLC.":[186,224],"addition,":[188],"this":[189,297],"possesses":[191],"c-MYC":[195],"1.03":[198],"e-05),":[199],"repressor":[202],"miR-200.":[204],"A":[205,259,328],"second":[206],"defined":[210],"reduced":[212],"miR-378,":[215],"whose":[218],"predicts":[220],"This":[225,365],"also":[228],"typified":[229],"Wee1":[234],"5.91":[237],"e-04),":[238],"putative":[240,288],"target":[241],"SCLC,":[243],"inhibitors":[250],"phosphatase":[253],"1D":[254],"(PPM1D),":[255],"tropomyosin":[256],"receptor":[257],"(TrkA)":[260],"B-Raf":[262],"0.009,":[265],"0.011":[266],"0.032,":[268],"respectively).":[269],"third":[271],"distinguished":[274],"reduction":[276],"several":[278],"miRs":[279],"including":[280],"miRs-216":[281],"-217,":[283],"role":[289],"tumor":[291],"suppressors":[292],"pancreatic":[294],"adenocarcinoma.":[295],"Intriguingly,":[296],"shows":[299],"an":[300],"increase":[301],"multiple":[303],"proteins":[304],"immune":[307],"checkpoint":[308],"pathways,":[309],"such":[310],"programmed":[312],"death":[313],"ligand":[314],"(PDL-1),":[316],"cluster":[317],"differentiation":[319],"40":[320],"(CD40)":[321],"MHC":[323],"class":[324],"I":[325],"polypeptide-related":[326],"sequence":[327],"(MICA)":[329],"6.38":[332],"e-04,":[333],"0.016":[334],"0.039,":[336],"respectively)":[337],"suggesting":[338],"group":[340],"that":[341],"may":[342],"enhanced":[344],"response":[345,407],"immune-checkpoint":[347],"inhibition.":[348],"These":[349],"subtypes":[350],"are":[351],"divided":[352],"almost":[353],"equally":[354],"among":[355],"tested":[357],"constituting":[359],"34%,":[360,363],"32%":[361],"respectively.":[364],"at":[373],"level":[376],"provides":[378],"preliminary":[379],"evidence":[380],"regarding":[381],"expression,":[387],"between":[393],"Integrated":[399],"analysis":[400],"across":[401,428],"miRs,":[402],"mRNA,":[403],"represents":[408],"powerful":[410],"tool":[411],"for":[412,416,482],"identifying":[413],"candidate":[414],"biomarkers":[415],"insights":[423],"into":[424],"biological":[426],"SCLC.":[429],"Citation":[430],"Format:":[431],"Carl":[432],"M.":[433],"Gay,":[434],"Samrat":[435],"Kundu,":[436],"Lixia":[437],"Diao,":[438],"Bonnie":[439],"S.":[440],"Glisson,":[441],"Jing":[442],"Wang,":[443],"John":[444],"V.":[445],"Heymach,":[446],"Lauren":[447],"A.":[448],"Byers,":[449],"Don":[450],"L.":[451],"Gibbons.":[452],"Unique":[453],"microRNA":[454],"signatures":[455],"correlate":[461],"profiles":[466],"response.":[469],"[abstract].":[470],"In:":[471],"Proceedings":[472],"107th":[475],"Annual":[476],"Meeting":[477],"American":[480],"Association":[481],"Cancer":[483,494],"Research;":[484],"2016":[485],"Apr":[486],"16-20;":[487],"New":[488],"Orleans,":[489],"LA.":[490],"Philadelphia":[491],"(PA):":[492],"AACR;":[493],"Res":[495],"2016;76(14":[496],"Suppl):Abstract":[497],"nr":[498],"LB-170.":[499]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-08-23T00:00:00"}